Purple Biotech Ltd. (PPBT) stock
PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.71+0.03 (+1.79%)
Close on Nov 17, 2026Market cap $1.59MP/E 0.0Yield –
Purple Biotech revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2020 it was $1.00M, up 0.0% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $1.00M | 0.0% |
| FY2019 | Dec 31, 2019 | $1.00M | 0.0% |
| FY2018 | Dec 31, 2018 | $1.00M | +900.0% |
| FY2017 | Dec 31, 2017 | $100.00K | – |
See a number that looks wrong?